Attitudinal determinants of fasting in type 2 diabetes mellitus patients during ramadan

Journal of Association of Physicians of India

Volumn 59, Issue 10, 2011, Pages 630-634

  Fatima, Jalees ^a   Karoli, Ritu ^a   Chandra, Ashok ^a   Naqvi, Nigar ^a  

^a Era's Lucknow Medical College   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; DIET; DIET RESTRICTION; FEMALE; HUMAN; HYPOGLYCEMIA; INDIA; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RELIGION;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; DIET; FASTING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INDIA; ISLAM; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; QUESTIONNAIRES;

EID: 80053614444     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. An analysis of the world Muslim population by country/ region [article online]. Available at http://www.factbook.net/muslim_pop.php. Accessed 14 April 2005
2. Cheah JS, Wang KW, Sum CF, Epidemiology of Diabetes mellitus in the Asia-Pacific region, Ann Acad Med Singapore 1990;4:501-50,.
3. International Meeting on Diabetes and Ramadan Recommendations: Edition of the Hassan II Foundation for Scientific and Medical Research on Ramadan. Casablanca, Morocco, FRSMR, 1995.
4. Chandalia HB. Bhargav A. Kataria V. Dietary pattern during Ramazan Fasting and its Effect on the Metabollic control of Diabetes. Practical Diabetes 1987;4:287-90.
5. Uysal AR, Erdogan MF, Sahin, G, Kamel N. Erdogan G: Clinical and metabolic effects of fasting in 41 type 2 diabetic patients during Ramdan (Letter). Diabetes Care 1998;21:2033-2034.
6. Aslam M, Healey MA. Compliance and drug therapy in Moslem patients. J Clin Hosp Pharm 1986;11:321-5.
7. Aslam M, Assad A. Drug regimens and fasting during Ramadan: a survey in Kuwait. Public health 1986;100:49-53.
8. th American Endocrine Society Annual meeting, San Diego, California, 4-7 June 2005. Chevy Chase, MD. The Endocrine society.
9. Elhadd TA, AL-Amoudi A Recommendations for Management of Diabetes during Ramadan: Diabetic Care 2006;29:744-745.
10. American Diabetes Association. Clinical Practice Recommendations. Diabetes Care 2007;30:S4.
11. Salti I, Benard E, Detournay B, Bianch-Biscay M, Le Brigand C, Voinet C, Jabbar A, the EPIDIAR Study Group: A populationbased study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the Epidemiology of Diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 2004;27:2306-2311.
12. Al-Arouj M., Bouguerra R., Buse J., Hafez S, Hassanein M, Ibrahim MA, Ismah-Begi F, El-Kebbi I, Khatib O, Kishawi S, Al-Madani A, Mishal AA, Al-Maskari M, Nakhi AB, Al-Rubean K, Recommendations for Management of Diabetes During Ramadan. Diabetes Care 2005;28:2305-2311.
13. Azizi F, Siahkolah B: Ramadan fasting and diabetes mellitus. Int J Ramadan Fasting Res 1998;2:8-17
14. Zargar AH, Siraj M, Jawa A.A. Hasan M, Mahtab H. Maintenance of glycaemic Control with the evening administration of a long acting sulphonylurea in male type 2 diabetic patients undertaking the Ramazan fast. Int J Clin Pract 2010;64:1090-4.
15. Vasan S., Thomas N., Bharani MD., Mohammed Ameen, Abraham S, Victoria Job. et al. A Double blind. Randomised. Multi- center study evaluating the effects of pioglitazone in fasting Muslim Subjects during Ramadan. Intl J Diab Dev Countries 2006;26:2:66-72.
16. Chandalia HB. Ramazan fast and control of diabetes. Int J Diab Dev Ctries 2006;26:49-50.